Insulet Corporation's stock gained momentum after Benchmark initiated coverage with a 'Buy' rating and a $250 price target. The company also announced the opening of its new headquarters in Riyadh, further boosting investor confidence.
Insulet (PODD) Rises on Benchmark Upgrade, Riyadh HQ Opening
|1 min read
Stock UpgradeMedical DevicesPODDAnalyst RatingSaudi Arabia